LEONARD JOHN M - Insider Non-Derivative Transactions at Intellia Therapeutics, Inc. (NTLA) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Dec 12, 2025, LEONARD JOHN M's relationship to Intellia Therapeutics, Inc. (NTLA) is Director,Officer (President and CEO), and currently has 1,047,485 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other NTLA insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

LEONARD JOHN M - Insider Non-Derivative Transactions of NTLA Common Stock

LEONARD JOHN M - Insider Non-Derivative Transactions at NTLA

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Dec 13, 2025	M -- (Common Stock)	8557	6.83	1047485
Dec 12, 2025	Sell -- (Common Stock)	5355	9.59	1038928
Dec 12, 2025	Sell -- (Common Stock)	32832	9.47	1044283
Dec 12, 2025	Sell -- (Common Stock)	49959	9.49	1077115
Dec 12, 2025	M -- (Common Stock)	49959	6.83	1127074
Mar 2, 2025	Acquisition -- (Common Stock)	136000	0	1077115
Jan 4, 2025	Sell -- (Common Stock)	26807	12.18	941115
Jan 2, 2025	M -- (Common Stock)	7850	0	967922
Mar 2, 2024	Acquisition -- (Common Stock)	113586	0	960072
Jan 4, 2024	Sell -- (Common Stock)	19223	29.46	846486
Jan 2, 2024	M -- (Common Stock)	7848	0	865709
Mar 2, 2023	Acquisition -- (Common Stock)	91036	0	857861
Jan 5, 2023	Sell -- (Common Stock)	6673	37.21	766825
Jan 2, 2023	M -- (Common Stock)	7848	0	773498